The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).
Jul 12, 2024
0
1
University of Oklahoma researchers have deepened their understanding of a drug's ability to prevent fat buildup in the liver, a condition that often occurs with obesity and can lead to serious fatty liver disease. Their findings—which ...
May 23, 2024
0
79
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, representing more than 30% of all pediatric cases. A pilot study in The Journal of Molecular Diagnostics confirms the feasibility of implementing an ...
Jan 29, 2024
0
0
Cases of vision loss and deaths are mounting in an investigation into eye drops contaminated with a rare strain of the drug-resistant bacteria, Pseudomonas aeruginosa.
May 23, 2023
0
9
Stanford Medicine researchers have discovered a possible new way to treat pain without the use of opioids. By targeting a specific area of a well-known pain receptor, they were able to reduce pain sensitivity in mice without ...
Feb 2, 2023
0
67
Chromium picolinate is a supplement that many folks take, as it's touted to unlock insulin, burn fat and build muscle.
Jan 31, 2023
0
11
Sensitive skin is a pain—sometimes literally—and for skin allergy sufferers, contact with an allergen causes an itchy red rash that may last for weeks. Common skin care products such as soaps, serums and lotions (often ...
Dec 12, 2022
0
10
Cells in the surrounding tumor microenvironment have a significant impact on cancer growth, survival and responses to therapy. Cancer-associated fibroblasts in the tumor environment have typically been associated with tumor ...
Aug 16, 2022
0
143
Parkinson's is a progressive and debilitating disease of the brain that eventually compromises patients' ability to walk and even to talk. Its diagnosis is complex, and in the early stages—impossible.
Jul 15, 2022
0
80
Hundreds of organizations including drug companies, NHS commissioners, and universities have breached patient data sharing agreements in the past seven years, reveals an investigation by The BMJ today.
May 11, 2022
0
5
